Source: International Congress 2018 – Experimental research in pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Horiuchi (Matsumoto, Japan), Y. Droma (Matsumoto, Japan), F. Kinota (Matsumoto, Japan), N. Kobayashi (Matsumoto, Japan), M. Ota (Matsumoto, Japan), M. Hanaoka (Matsumoto, Japan). Gene-Gene Interaction between EPAS1 and EGLN1 in Patients with High-Altitude Pulmonary Edema. 3060

Member's Comments

No comment yet.

Related content which might interest you: Multi-Omics Analysis of the PDGF Response in Pulmonary Vascular Smooth Muscle Cells from Patients with Pulmonary Arterial Hypertension: Implication of the NMDAR Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Metered Cryospray Modulates Bronchial Epithelial Gene Expression in Patients with Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Interventional pulmonology: unity in diversity Year: 2020 Right Ventricular Failure in an Animal Model of Severe Pulmonary Arterial Hypertension: eNOS Uncoupling and Protein Kinase G Signaling in the Transition from Adaptive to Maladaptive Remodeling Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 mTOR Pathway Activation Drives Lung-Cell Senescence and Emphysema in Chronic Obstructive Pulmonary Disease Source: International Congress 2017 – Translational studies of lung disease Year: 2017 Differential Expression of Plasma Metabolites in Patients with Pulmonary Sarcoidosis is Associated with Clinical Behavior Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 Physical Training Improves Lung Function and Mechanics and Pulmonary and Systemic Immune Response in Eutrophic Women Source: Virtual Congress 2020 – Novel insights into exercise training Year: 2020 Aerobic Training Improves Pulmonary and Systemic Inflammatory and Fibrotic Response in Asthmatics Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021 Acetylsalicylic Acid Prevents Intermittent Hypoxia-Induced Vascular Remodeling in a Murine Model of Sleep Apnea Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia Year: 2018 Implication of Enhancer of Zeste Homolog 2 in Pulmonary Arterial Hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Late Breaking Abstract - Chronic Hypoxia Promotes Pulmonary Venous Smooth Muscle Cells Proliferation by Upregulating Calcium Sensing Receptor Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 Smart Watch-based Coaching with Tiotropium and Olodaterol Ameliorates Physical Activity in Chronic Obstructive Pulmonary Disease Patients Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017 Risk Factor for Chronic Obstructive Pulmonary Disease in Never-Smoker Patients with Non-Cystic Fibrosis Bronchiectasis Source: International Congress 2019 – Bronchiectasis Year: 2019 Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 A First-in-Class PRS Inhibitor, DWN12088, as a Novel Therapeutic Agent for Systemic Sclerosis and Associated Interstitial Lung Disease Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 Low Level of  Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease Source: International Congress 2017 – COPD biomarkers Year: 2017 Marathon Running Modulates Lung Mechanics and Pulmonary and Systemic Immune Response in Amateur Athletes Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy Year: 2020 Endothelial dysfunction in High Altitude Pulmonary Edema: Risk factors and Biomarkers Source: ERS Research Seminar 2016 - Pulmonary Vascular Endothelium: Orchestra Conductor in Respiratory Diseases - Highlights from Basic Research to Therapy Year: 2016